Different inflammatory cells and cytokines in ICC patients with HBV infection or hepatolithiasis probably result in distinct immune microenvironments including different profiles of PD1/PD-L1, and patients' outcomes. The gene discussed is CD274; the disease is intrahepatic cholangiocarcinoma.